Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Top highlights include: A gull flaps its wings and a deadly virus explodes, Doctors increasingly prescribe time in nature to promote mental and physical health, Father's Day miracle: newborn receives organ donation right on time Minnesota.
The Department of Health and Human Services has named Mayo Clinic Laboratories as one of five commercial laboratories to expand access and capacity for monkeypox testing.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss what the increasing monkeypox cases are revealing, and regulatory updates on the VALID Act and PAMA.
Featured Abstract: A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
Guided by a patient-centric philosophy, Mayo Clinic Laboratories has a unique internal structure of quality specialists, coordinators, and engineers who constantly evaluate and improve laboratory operations. This structure supports a host of quality assurance activities.
Top highlights include: Remission Seen in Every Rectal Cancer Patient in Small Study of Drug, Mayo Clinic urges men to get check-ups ahead of Father's Day, Getting closer to a vaccine for cancer.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with ¬¬¬¬¬Dr. Jeffrey Winters, Chair of the Division of Transfusion Medicine, and Professor of Laboratory Medicine and Pathology at Mayo Clinic, to talk about the new AABB guidelines for convalescent plasma.
This July, Mayo Clinic’s Neuroimmunology Laboratory will showcase its revolutionary approach to autoimmune neurology testing at the American Academy of Neurology (AAN) Summer Conference: Autoimmune Neurology and Neurology Year in Review in San Francisco. During the meeting, Mayo Clinic Laboratories representatives will highlight our growing list of disease-specific tests and discuss how results can inform decision-making and improve treatment outcomes.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the latest developments in monkeypox, the reality of living in the age of pandemics, and the importance of testing and public-private partnerships.
As director of Regulatory Affairs for the Department of Laboratory Medicine and Pathology, Shannon Bennett helps safeguard Mayo Clinic’s reputation for quality care by ensuring that its clinical laboratories operate at the highest level of regulatory compliance.
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small insertions or deletions, and copy number variants on approximately 20,000 genes, enabling precision answers to accurately diagnose, manage, and treat patients with identified inherited illness.
Featured Abstract: Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.